iScience (Jun 2024)

CRISPR-Cas9 screening reveals a distinct class of MHC-I binders with precise HLA-peptide recognition

  • Tom A.W. Schoufour,
  • Anneloes van der Plas - van Duijn,
  • Ian Derksen,
  • Marije Melgers,
  • Jacqueline M.F. van Veenendaal,
  • Claire Lensen,
  • Mirjam H.M. Heemskerk,
  • Jacques Neefjes,
  • Ruud H.M. Wijdeven,
  • Ferenc A. Scheeren

Journal volume & issue
Vol. 27, no. 6
p. 110120

Abstract

Read online

Summary: Human leukocyte antigen (HLA) class-I molecules present fragments of the cellular proteome to the T cell receptor (TCR) of cytotoxic T cells to control infectious diseases and cancer. The large number of combinations of HLA class-I allotypes and peptides allows for highly specific and dedicated low-affinity interactions to a diverse array of TCRs and natural killer (NK) cell receptors. Whether the divergent HLA class-I peptide complex is exclusive for interactions with these proteins is unknown. Using genome-wide CRISPR-Cas9 activation and knockout screens, we identified peptide-specific HLA-C∗07 combinations that can interact with the surface molecules CD55 and heparan sulfate. These interactions closely resemble the HLA class-I interaction with the TCR regarding both the affinity range and the specificity of the peptide and HLA allele. These findings indicate that various proteins can specifically bind HLA class-I peptide complexes due to their polymorphic nature, which suggests there are more interactions like the ones we describe here.

Keywords